Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
genentech
3
×
life sciences
national blog main
novartis
europe top stories
fda
gene therapy
national
national top stories
roche
san francisco top stories
acute lymphoblastic leukemia
avapritinib
billy dunn
biogen
blueprint medicines
boston
boston blog main
boston top stories
cancer
cancer drugs
capmatinib
catalyst healthcare consultants
cell therapy
clinical trials
drug information association
drug prices
drug pricing
elevatebio
eli lilly
europe blog main
evrysdi
gastrointestinal stromal tumors
indiana blog main
indiana top stories
ionis pharmaceuticals
karen walker
kymriah
life science
What
fda
therapy
3
×
drug
new
address
approval
approved
approves
atrophy
blueprint
cancer
carries
certain
chemistry
cmc
consistent
controls
daily
designed
ensure
evrysdi
friday
gene
genetic
green
home
intended
lack
latest
lights
liquid
manufacturing
medicine
medicines
muscular
needed
official
oral
pass
patients
Language
unset
Current search:
genentech
×
therapy
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
